Mediar will receive a combined $99m consisting of an upfront payment and near-term milestones.
Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment
January 13, 2025
You may also like
Indices by TradingView
Categories
Indices by TradingView